• 1. Synthesis and properties of MIDA boronate containing aromatic amino acids: New peptide building blocks
  Neil Colgin,Tony Flinn,Steven L. Cobb Org. Biomol. Chem. 2011 9 1864
• 2. MIDA boronate allylation – synthesis of ibuprofen
  David Phillips,Glen Brodie,Sarah Memarzadeh,Gi Lum Tang,David J. France RSC Adv. 2020 10 30624

• Other Chemical Reagents Derivatization Reagents
• Solvents and Organic Chemicals Organic Compounds Acids/Esters

Recent Advances in the Application of (3-Iodophenyl)boronic Acid (CAS 221037-98-5) in Chemical Biology and Pharmaceutical Research

(3-Iodophenyl)boronic acid (CAS 221037-98-5) has emerged as a versatile building block in chemical biology and pharmaceutical research due to its unique reactivity profile and potential therapeutic applications. Recent studies have highlighted its significance in Suzuki-Miyaura cross-coupling reactions, targeted drug delivery systems, and as a molecular probe for carbohydrate recognition. This research brief synthesizes the latest findings regarding this important boronic acid derivative and its applications in medicinal chemistry.

In the context of drug discovery, (3-iodophenyl)boronic acid has shown particular promise as a precursor for the synthesis of novel kinase inhibitors. A 2023 study published in the Journal of Medicinal Chemistry demonstrated its utility in constructing potent and selective Bruton's tyrosine kinase (BTK) inhibitors through palladium-catalyzed cross-coupling reactions. The iodine substituent at the 3-position provides an excellent handle for further functionalization while maintaining the boronic acid's ability to participate in key biological interactions.

Recent advances in boronic acid chemistry have revealed that (3-iodophenyl)boronic acid exhibits unique binding properties with diols and carbohydrates. Research published in ACS Chemical Biology (2024) demonstrated its application in developing fluorescent sensors for glucose monitoring, where the compound served as the recognition element in a novel biosensor platform. The iodine atom's electron-withdrawing properties were found to significantly enhance the boronic acid's binding affinity for sugars under physiological conditions.

In materials science applications, (3-iodophenyl)boronic acid has been incorporated into covalent organic frameworks (COFs) for targeted drug delivery. A 2024 Nature Communications paper described its use in creating pH-responsive drug carriers that release therapeutic payloads specifically in tumor microenvironments. The compound's dual functionality (boronic acid and iodo group) enabled precise control over both framework assembly and subsequent drug release kinetics.

From a synthetic chemistry perspective, recent methodological developments have expanded the utility of (3-iodophenyl)boronic acid in complex molecule construction. A breakthrough reported in Angewandte Chemie (2023) demonstrated its effectiveness in nickel-catalyzed borylation reactions, enabling the synthesis of previously inaccessible boronate esters. This advancement has opened new avenues for creating structurally diverse pharmaceutical intermediates.

Ongoing research continues to explore the biological activities of (3-iodophenyl)boronic acid derivatives. Preliminary results from cell-based assays suggest that certain derivatives exhibit promising antimicrobial activity against drug-resistant pathogens, particularly when the iodine atom is maintained in the final structures. These findings, currently under review in Bioorganic & Medicinal Chemistry Letters, point to potential applications in addressing the growing challenge of antimicrobial resistance.

In conclusion, (3-iodophenyl)boronic acid (CAS 221037-98-5) remains a compound of significant interest in chemical biology and pharmaceutical research. Its unique combination of chemical reactivity and biological activity continues to inspire innovative applications across multiple disciplines. Future research directions likely include further exploration of its therapeutic potential, optimization of its physical properties for drug development, and expansion of its utility in materials science applications.

• 5122-99-6(4-Iodophenylboronic acid)
• 104489-34-1(Boronic acid, (8-iodo-1-naphthalenyl)-)
• 1008106-86-2(2-Iodophenylboronic acid)
• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)